Global Rheumatoid Arthritis Market Report

As per this study the Global Rheumatoid Arthritis Market was valued USD 32.77 BN (by revenue) in 2021 and is anticipated to reach USD 47.67 BN by 2028 with a CAGR of 5.5%.
 
Rheumatoid arthritis is a chronic autoimmune disorder that majorly affects the body joints. Initially, it affects joints of hands and toes, knees, ankles, elbows, hips but in case of severity may affect non-joint structures such as skin, lungs, blood vessels, nerve tissue and bone marrow. Common symptoms of rheumatoid arthritis are joint pain, soft and swollen joints along with constant fatigue, fever and weight loss.
 
Objectives of the Study:

• Define and measure the global rheumatoid arthritis market
• Revenue forecast of the global rheumatoid arthritis market and its various sub-segments with respect to main geographies
• Analyze and identify major market trends along with the factors driving or inhibiting the market growth
• Study the company profiles of the major market players with their market share
• Analyze competitive developments

 
Market Dynamics
 
Rising count of patients suffering from arthritis and growing geriatric population are the key drivers driving the market growth. Rising adoption of generic drugs and novel therapies to treat the condition is fueling the demand of rheumatoid arthritis drugs. However, high cost of treatment may hinder the market growth in forecasting period.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of rheumatoid arthritis.
 
Market Segmentation
 
The broad rheumatoid arthritis market has been sub-grouped into treatment and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Treatment

• Symptomatic Treatment
• Intermediate Corticosteroid Treatment
• Disease Modifying Anti-Rheumatic Drug {DMARD} Therapies
  • Conventional DMARD
  • Biologic DMARD

 
By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores

 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for rheumatoid arthritis in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Rheumatoid Arthritis Market Share by Region (Representative Graph)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the rheumatoid arthritis market include AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly & Company, F. Hoffman-La Roche AG, Johnson & Johnson, Pfizer Inc., Sanofi SA, Sobi Inc., UCB S.A., and others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.